Classification
Product TypeProcessed Food
Product FormLiquid (oil-based astaxanthin supplement/ingredient)
Industry PositionConsumer Health Product (Dietary Supplement)
Market
Liquid astaxanthin supplement products are typically formulated from astaxanthin-rich oleoresin derived from cultivated microalgae (notably Haematococcus pluvialis) and standardized in edible carrier oils for consistent dosing. In regulated markets, specifications and permitted uses for algal astaxanthin ingredients can be anchored to formal novel food authorisations (EU) and dietary supplement manufacturing rules (US). Commercial-scale natural astaxanthin supply for human supplements is associated with vertically integrated microalgae cultivation and extraction operations in locations such as the United States (Hawaii), Sweden, and Israel. Market positioning is strongly shaped by “natural algal” provenance versus other sources, along with documentation quality (specifications, contaminant testing, and manufacturing compliance) to avoid border rejections and recalls.
Market GrowthNot Mentioned
Major Producing Countries- 미국Natural astaxanthin production from Haematococcus pluvialis is marketed as grown and extracted in Hawaii by Cyanotech (BioAstin).
- 스웨덴AstaReal describes commercial production of natural astaxanthin from Haematococcus pluvialis and a production facility in Sweden.
- 이스라엘Algatech markets natural astaxanthin derived from Haematococcus pluvialis and describes cultivation under the Arava desert sun.
Major Exporting Countries- 미국Finished and bulk astaxanthin products are marketed as sold internationally by a Hawaii-based producer (Cyanotech/Nutrex Hawaii).
- 스웨덴AstaReal positions itself as a global supplier of natural astaxanthin products, implying routine cross-border ingredient trade.
- 이스라엘Algatech markets bulk astaxanthin ingredient formats (e.g., oleoresin, beadlets, softgels) for global B2B use.
Specification
Major VarietiesAstaxanthin-rich oleoresin from Haematococcus pluvialis (standardized in edible oils), Algal meal/biomass from Haematococcus pluvialis containing astaxanthin (ingredient format)
Physical Attributes- Deep red carotenoid pigment; typically handled as a lipophilic (oil-based) ingredient for liquid supplements
Compositional Metrics- EU novel food specification for astaxanthin-rich oleoresin from Haematococcus pluvialis includes standardisation using edible oils (e.g., olive, safflower, sunflower, MCT) and defined carotenoid-profile limits (including total astaxanthins and isomer/ester fractions).
- EU novel food specification includes microbiological criteria (e.g., limits for total aerobic bacteria, yeasts/moulds, coliforms; absence criteria for E. coli and Salmonella) for astaxanthin-rich oleoresin ingredients.
Grades- Standardised oleoresin concentrations used in trade (e.g., 2.5%, 5%, 7%, 10%, 15%, 20% astaxanthin in carrier oils) per EU novel food specification language
ProcessingEU novel food specification describes extraction via supercritical CO2 or solvent (ethyl acetate), followed by dilution/standardisation in edible oils for consistent potency.Commercial production narratives commonly describe staged microalgae cultivation (green growth phase to red astaxanthin-accumulation phase), harvest/drying, then extraction and downstream formulation into oil-based products.
Supply Chain
Value Chain- Haematococcus pluvialis cultivation (photobioreactors and/or ponds) -> biomass harvest and drying -> oleoresin extraction (e.g., supercritical CO2 or permitted solvent) -> standardisation in edible carrier oil -> blending/formulation into liquid supplement format -> packaging -> global distribution
Demand Drivers- Ingredient demand for food supplements and adjacent fortified-food applications in jurisdictions where algal astaxanthin ingredients are authorised/regulated as novel foods
- Premiumisation and differentiation tied to natural microalgae-derived provenance, documented specifications, and manufacturing compliance
Risks
Regulatory Compliance HighAstaxanthin ingredient legality, conditions of use, and specifications differ across jurisdictions (e.g., EU novel food authorisations/spec updates and US dietary supplement manufacturing requirements). Non-compliance can trigger import detentions, forced relabelling, withdrawals, or recalls, disrupting trade flows and increasing cost-to-serve.Map intended uses and maximum levels by destination market; source ingredients that match the destination’s authorised specification; maintain complete documentation (specifications, CoAs, traceability) and manufacture under applicable dietary supplement cGMP/HACCP systems.
Product Integrity MediumQuality variability and misrepresentation risk (e.g., potency standardisation, source/provenance claims, and microbiological/contaminant compliance) can lead to buyer rejections and reputational damage in a premium-priced supplement category.Use validated analytical methods (e.g., HPLC potency/profile testing) and release testing aligned to specification limits; audit upstream cultivation/extraction controls and conduct periodic third-party verification.
Stability And Oxidation MediumAs a carotenoid ingredient typically supplied in oil-based form, astaxanthin products can be sensitive to degradation drivers (light/heat/oxygen exposure), reducing label-claim potency over time and increasing dispute risk across long distribution chains.Specify protective packaging and storage conditions; include stability programs and shelf-life verification; control exposure during filling and distribution.
Sustainability- Energy and solvent-management footprint variability across production pathways (closed photobioreactors vs open ponds; supercritical CO2 vs solvent extraction) can affect buyer ESG screening and audit outcomes.
FAQ
How is astaxanthin-rich oleoresin for liquid supplements typically produced?A common pathway is cultivation of Haematococcus pluvialis microalgae, harvesting and drying the algal cells, extracting oleoresin (the EU specification describes supercritical CO2 or ethyl acetate extraction), and then diluting/standardising the oleoresin in edible carrier oils to achieve a consistent potency for formulation.
Why do bulk astaxanthin ingredients often come as a standardized percentage (for example 5% or 10%)?Standardising the oleoresin in carrier oils allows manufacturers to use a consistent-strength ingredient when dosing into liquids or softgels. The EU novel food specification explicitly describes standardisation to set concentrations (including 2.5% through 20%) using edible oils such as olive, safflower, sunflower, or MCT.
What compliance checkpoints most often affect cross-border trade of astaxanthin supplements?Two recurring checkpoints are (1) destination-market ingredient authorisation/specifications (for example, EU novel food specifications and their updates for Haematococcus-derived astaxanthin ingredients) and (2) manufacturing system compliance for dietary supplements (for example, US dietary supplement cGMP requirements under 21 CFR Part 111), supported by documentation and testing such as microbiological criteria and potency verification.